Matrix metalloproteinase (MMP) are predictors of inflamation severity and markers of tissue remodeling.
The goal is to identify the parameters of the MMP / inhibitors system in ITL in the dynamics of the intensive phase of treatment (IFT) to develop a model for predicting reparative changes.